CLINICAL_TRIALS
trial_result
· 2021-11-22
Clinical Trial Update: A Phase 2 Study of CIM331 for Atopic Dermatitis Patients [Phase 2]
Summary
Phase 2 trial of CIM331 for atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chugai Pharmaceutical | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2021-11-22